Analysen von Richard Vosser
| 10.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.08.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 04.08.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 04.08.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 03.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.08.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 01.08.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 31.07.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.07.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 27.07.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.07.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.07.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 25.07.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 25.07.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 24.07.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.07.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 24.07.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 21.07.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 19.07.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 19.07.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.07.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 18.07.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 10.07.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 06.07.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.07.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.06.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 29.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 29.06.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 27.06.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.06.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 26.06.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 26.06.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 20.06.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 19.06.23 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 19.06.23 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 09.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 31.05.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 26.05.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 22.05.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 19.05.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 15.05.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 11.05.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 11.05.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 08.05.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 05.05.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.05.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 04.05.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 03.05.23 | Bayer Neutral | JP Morgan Chase & Co. | |